AGAMATRIX

In News

AgaMatrix, Inc. And WaveForm Technologies, Inc. Complete $56 Million Capital Raise - PR Newswire

PR Newswire - Jul 03, 2019

Choice: A New Amazon Brand for Blood Glucose Meters - Making Sense of Diabetes

Making Sense of Diabetes - May 05, 2024

AgaMatrix raises $56M to develop and sell its WaveForm CGM - Fierce Biotech

Fierce Biotech - Jul 08, 2019

AgaMatrix lands $32m loan for split - Drug Delivery Business

Drug Delivery Business - Oct 06, 2017

i-SENS acquires US glucose measuring device maker - koreabiomed.com

koreabiomed.com - May 17, 2023

S.Korea's i-Sens buys US glucose-measuring device maker for $27 mn - KED Global

KED Global - May 18, 2023

AgaMatrix’s technology now part of Choice’s diabetes line - NH Business Review

NH Business Review - Nov 01, 2018

Dexcom beats WaveForm's patent suit over CGM sensors - MedTech Dive

MedTech Dive - Aug 26, 2019

AgaMatrix and Glytec Announce Partnership to Deliver a Cloud-Based Diabetes Management Platform to Improve Clinical Insights and Patient Blood Glucose Control - PR Newswire

PR Newswire - Jun 08, 2017

AgaMatrix raises $56m for WaveForm CGM - Drug Delivery Business

Drug Delivery Business - Jul 03, 2019

AgaMatrix Enters Strategic Partnership with Arcadia Group for Choice Brand Diabetes Monitoring Devices - PR Newswire

PR Newswire - Oct 31, 2018

i-SENS' Q2 operating income plunges by 49% - koreabiomed.com

koreabiomed.com - Aug 01, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment